Treatment of Mitral Regurgitation
Female Male P Female Male P Female Male P Hofman [15] Estévez [14] Attizani [13] Female patients, n 205 362 <0.0001 64 109 <0.0001 65 106 <0.0001 Age, %…
Female Male P Female Male P Female Male P Hofman [15] Estévez [14] Attizani [13] Female patients, n 205 362 <0.0001 64 109 <0.0001 65 106 <0.0001 Age, %…
Female (n = 1967) Male (n = 2005) p value Age, years 84.0 ± 6.6 81.6 ± 7.5 <0.001 Body mass index, kg/m2 25.7 ± 5.4 26.3 ± 4.5…
Fig. 14.1 3D anatomy of the left atrium with the Rhythmia System (posterior-anterior- and left lateral view). In both pictures you can see the multipolar mapping catheter (Orion) in the…
Fig. 12.1 Panel (a1) shows the Watchman device (Boston Scientific), and Panel (b1) shows the Amplatzer Cardiac Plug 2 (ACP 2 or Amulet™, St. Jude Medical). Below are images of…
Grade Mobility Subvalvular thickening Thickening Calcification 1 Highly mobile valve with only leaflet tips restricted Minimal thickening just below the mitral leaflets Leaflets near normal in thickness (4–5 mm) A…
Typical symptoms Atypical symptoms Chest pain Pressure Tightness Squeezing Sharp Pleuritic Burning Aching Soreness Reproducible Additional symptoms Irradiation of pain to neck, jaw, shoulders, arms, and back Dyspnea Nausea…
Feature Histology OCT IVUS In general Resolution 1 μm 10–20 μm 100–250 μm Imaging depth ∞ 1–2.5 mm 8–10 mm Detailed surface morphology + + – Vessel remodeling + –…
Fig. 7.1 (a) BAV performed with a 22 mm balloon catheter in a woman with a mean annuls diameter of 21 mm. (b) Annulus rupture through the free LV myocardial…
Fig. 4.1 Recommended indications for the invasive and conservative strategies for the treatment of NSTE-ACS according to risk stratification (MI myocardial infarction, CKD chronic kidney disease, LVEF left ventricular ejection…
Drug Comparison Type of study Indication No. of individuals Follow-up Efficacy endpoint Relative risk (95 % CI) Safety endpoint Relative risk (95 % CI) Reference Acetylsalicylic acid Acetylsali-cylic acid Placebo…